Breast Cancer News
In this section, access cutting-edge breast cancer news on treatment updates, emerging therapies, study results and other medical and quality-of-life issues important to you.
Researchers with the phase II GeparSixto trial found that women with triple-negative breast cancer were significantly more likely to achieve pathological complete response, or pCR, when carboplatin was added to their course of other anti-cancer medicines. For this study, pCR was defined as the absence of cancer after treatment given before surgery.
A recent study published in The New England Journal of Medicine looked at harmful mutations, or changes in the DNA of a cell, found on the PALB2 gene. The study found that, like BRCA1 and BRCA2 gene mutations, PALB2 mutations greatly increase a person’s chance of getting breast cancer.
LBBC highlights a study reported on the first day of the American Society of Clinical Oncology 2014 Breast Cancer Symposium: an analysis of breast cancer recurrence rates after pre-surgery, or neoadjuvant, chemotherapy.
Although more women are having lumpectomies, an evaluation of data in the National Cancer Database found socioeconomic barriers prevent some from choosing this surgery. Meeghan Ann Lautner, MD, of the University of Texas San Antonio, announced findings at the American Society of Clinical Oncology 2014 Breast Cancer Symposium on September 4.
Everolimus May Help Those With HER2-positive Breast Cancer That No Longer Responds Well to Trastuzumab
Adding everolimus could make trastuzumab work better in women who aren’t seeing the same benefits this medicine once gave them. But everolimus isn’t without risk – it has the potential to lower the user’s quality of life.
A panel of experts reviewed key points and limitations of a new national guideline on margins for lumpectomy, also called breast-conserving surgery, at the American Society of Clinical Oncology 2014 Breast Cancer Symposium in San Francisco yesterday. They also discussed how it can be used in clinical practice.
Findings about the influence of PALB2 gene mutations on the risk of getting breast cancer could influence genetic testing. They could also affect the way people with a mutation on this gene make treatment decisions in the future.
Two recent studies found that those diagnosed with breast cancer at younger ages are more likely to experience difficulties with certain symptoms and side effects than those diagnosed when older.
Getting advice about healthy living by phone from trained lifestyle coaches may help some overweight women treated for early-stage breast cancer lose more weight, a new study shows.
When Looking at Older Women, Researchers See Links Between Frailty, Race and Failing to Start Hormonal Therapy
A study reported in the Journal of Clinical Oncology found most older women with hormone receptor-positive breast cancer follow their doctors’ orders to begin hormonal therapy. But those numbers are not as high when looking at non-white women and those deemed “frail.”